> top > docs > PubMed:2651467

PubMed:2651467 JSONTXT

Production scale purification of biosynthetic human insulin by reversed-phase high-performance liquid chromatography. A process based on reversed-phase high-performance liquid chromatography (RP-HPLC) has been developed for the purification of biosynthetic human insulin (BHI). The RP-HPLC procedure has been successfully integrated into the multimodal chromatographic production process used to purify kilogram quantities of BHI. Axial compression column technology was used in the scale-up process. The RP-HPLC procedure yields an insulin product having high chemical purity and full biological activity.

projects that include this document

Unselected / annnotation Selected / annnotation
Allie (0)